Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

Background In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy...

Descripció completa

Dades bibliogràfiques
Autors principals: Michael Foley, Christopher A. Rajkumar, Matthew Shun‐Shin, Sashiananthan Ganesananthan, Henry Seligman, James Howard, Alexandra N. Nowbar, Thomas R. Keeble, John R. Davies, Kare H. Tang, Robert Gerber, Peter O’Kane, Andrew S. P. Sharp, Ricardo Petraco, Iqbal S. Malik, Sukhjinder Nijjer, Sayan Sen, Darrel P. Francis, Rasha Al‐Lamee
Format: Article
Idioma:English
Publicat: Wiley 2021-02-01
Col·lecció:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:
adverse effects
angina
compliance/adherence
medical therapy
randomized controlled trial
Accés en línia:https://www.ahajournals.org/doi/10.1161/JAHA.120.017381

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017381

Ítems similars